AsiaDev.org
   EAST ASIA  |  SOUTH EAST ASIA  |  SOUTH ASIA  |  CENTRAL ASIA  |  PACIFIC  |  EDITORIAL  |  ChinaDev
     
A S I A -- R S S
People's Daily
China Post
China Dialogue
Shanghai Daily
Phayul
Mongolia Web
News On Japan
Taiwan News
Taiwan Headlines
Vietnam Biz Finance
Inquirer
New Straits Times
Channel NewsAsia
The Star
Jakarta Post
Antara
ANU Indonesia Project
New Nation
Business Standard
The Hindu
Business Line
Rediff
merinews
2point6billion
India-Briefing
Daily Mirror
Eurasianet
Radio Free Europe
Pacific Magazine
Islands Business
Pacific News Center
Fiji Times
Fiji Live
Asia Times
Asianews.it
The Economist
Business Times
Business Week
New York Times
BBC
CNN
IHT
ADB (publications)
ADB (news)
World Bank (E.Asia)
World Bank (S.Asia)
USAID
BIS (all updates)
BIS (papers)
OECD
UNICEF
WFP
WEF
WHO
WWF
NZAID
ReliefWeb
IRIN
Job opportunities
E D I T O R I A L
  DAILY REPORTS
Yaung's failure is no 'shock' for Taiwan (Mar 11)
The sudden resignation of Health Minister Yaung Chih-liang due to backtracking in President Ma Ying-jeou's right-wing Chinese Nationalist Party (Kuomintang) on national health insurance system


Comments: President SBY’s indecisiveness (Mar 11)
President SBY’s indecisiveness
March 4, p. 2
read more


Comments: Farmers seek to stub out govt regulation (Mar 11)
Farmers seek to stub out govt regulation
March 2, p. 5
read more


Are today's young the 'chump' generation? (Mar 11)
THE 'generation gap' endures as a staple of American political and social analysis.


Limits to taxing the super-rich (Mar 11)
TAXES for some people were actually raised in the recent Budget but judging by the apparent indifference of those affected, one could assume that these folks do not actually mind paying more.


Medicines for all (Mar 10)
Unrestricted entry of foreign equity into the Indian pharmaceuticals sector is being questioned on three grounds, one serious and two non-serious. The least serious of the three comes from the National Security Council, which has proposed that the sector be put on the sensitive list, requiring prior scrutiny by the Foreign Investment Promotion Board. This is difficult to understand as there is no intellectual property to guard against foreign takeover, the Indian industry being entirely generic. The second non-serious reason, given by the department of pharmaceuticals, is that Indian firms are not on a level playing field they do not have deep pockets to do the kind of R&D necessary for survival in a free-for-all which global firms do.


   CONTACT US |  RSS |  ChinaDev |  NewsOnVietnam |  NewsOnJapan Copyright © 2008, AsiaDev.org